In yet another reported work, Liu et al. analyzed the effects at the biological and molecular levels, leading to the anti-survival effects on mantle cell lymphoma (MCL), as a comparison between first- and second-generation BTK inhibitors (BTKi) [78]. Here, BTK is linked to mantle cell lymphoma.